lebrikizumab-lbkz
Brand: EBGLYSS
approved
Quick answer
lebrikizumab-lbkz (EBGLYSS), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- lebrikizumab-lbkz
- Brand
- EBGLYSS
- Route
- INJECTION
- Formulation
- INJECTABLE
Frequently asked questions
What is lebrikizumab-lbkz?
lebrikizumab-lbkz (EBGLYSS), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for lebrikizumab-lbkz?
EBGLYSS is a marketed brand name for lebrikizumab-lbkz. Check FDA Drugs@FDA for the current US label holder.